SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 06/09/2025 at 07:00, 7 months 29 days ago

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season, ensuring broad availability and high efficacy for infants

Healthcare Sanofi Vaccine RSV Beyfortus
BRIEF

published on 06/06/2025 at 20:27, 8 months 1 day ago

Sanofi Discloses Repurchase of Own Shares in Early June 2025

Share Repurchase XPAR Market Stock Transaction 2025 Sanofi
PRESS RELEASE

published on 06/06/2025 at 20:22, 8 months 1 day ago

Sanofi: Disclosure of trading in own shares
Sanofi discloses its trading in own shares from 02 June 2025 to 06 June 2025, repurchasing a total of 105,316 shares at an average price of 86.91 EUR per share on XPAR market

Trading Own Shares XPAR Repurchases Sanofi
BRIEF

published on 06/02/2025 at 07:05, 8 months 6 days ago

Sanofi to Acquire Blueprint Medicines for $9.5 Billion

Rare Diseases Sanofi Acquisition Blueprint Medicines Immunology Pipeline Systemic Mastocytosis
PRESS RELEASE

published on 06/02/2025 at 07:00, 8 months 6 days ago

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease. Acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis and a promising pipeline in immunology

Acquisition Sanofi Rare Diseases Blueprint Medicines Immunological Disease
BRIEF

published on 05/30/2025 at 07:05, 8 months 9 days ago

Itepekimab Reaches Primary Endpoint in COPD Phase 3 Study

Sanofi COPD Regeneron Itepekimab AERIFY-1
PRESS RELEASE

published on 05/30/2025 at 07:00, 8 months 9 days ago

Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
Itepekimab met primary endpoint in AERIFY-1 study for COPD, with significant reduction in exacerbations. AERIFY-2 did not meet endpoint. Sanofi and Regeneron assessing data for next steps

Sanofi COPD Regeneron Itepekimab AERIFY-1
BRIEF

published on 05/29/2025 at 14:35, 8 months 10 days ago

Positive impact of Beyfortus on hospitalizations due to RSV

Public Health Efficiency Beyfortus VRS Hospitalizations Childhood Vaccination
PRESS RELEASE

published on 05/29/2025 at 14:30, 8 months 10 days ago

Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
Real-world comparison shows Beyfortus and RSVpreF immunization programs reduce infant RSV hospitalizations in Spain and UK. Beyfortus provides sustained protection against RSV with high efficacy and safety profile

RSV Beyfortus RSVpreF Infant Immunization
BRIEF

published on 05/22/2025 at 01:20, 8 months 17 days ago

Sanofi acquires Vigil Neuroscience to strengthen its Alzheimer's research

Acquisition Alzheimer's Disease Sanofi Neurology Vigil Neuroscience

Accesswire

Published on 02/07/2026 at 01:00, 1 day 18 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 20 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 21 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 2 days 4 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 2 days 6 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 22 hours 53 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 1 day 3 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 1 day 3 hours ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 2 days ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 2 days 2 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 2 days 1 hour ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 2 days 3 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 3 days ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 3 days 1 hour ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 3 days 1 hour ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE